7. Оптимизация интенсивной терапии в условиях пандемии COVID-19 в городе Алматы
DOI:
https://doi.org/10.35805/BSK2023III007Загрузки
Аннотация
С момента начала распространения коронавирусной инфекции в мире, число зараженных превысило 102,5 млн человек, и более 2,2 млн человек умерли. В Казахстане, согласно мировой статистике COVID-19, отмечено 59-е место по числу выявленных случаев COVID-19 и 68-е место по смертности от коронавируса. У значительного большинства пациентов, болеющих COVID-19, заболевание протекает в легкой или средней форме, однако, у 5% при критическом течении заболевания, необходимо лечение в отделении интенсивной терапии. Продолжительность пребывания в отделении интенсивной терапии составляет в среднем 10,8 дня, однако у 22,7% пациентов продолжительность лечения в ОИТ превышает 30 дней. В целях улучшения результатов лечения, многие клиники используют методику бригадной работы, требующей достаточного числа высококвалифицированного медицинского персонала. Однако, в связи с нехваткой кадров в отделениях реанимации, принимаются меры по переподготовке медицинского персонала других специальностей. При этом, короткие курсы подготовки не всегда высококачественно улучшают результаты лечения и приводят к ухудшению результата большинства пациентов..
Ключевые слова
COVID-19 пандемия
Библиографические ссылки
- Gilardino, R.E. Does ‘Flattening the Curve’ Affect Critical Care Services Delivery for COVID-19? A Global Health Perspective. International Journal of Health Policy and Management 9, 12 (2020): 503-507
- M. Yang, H. Dong, Zh. Lu. “Role of Anaesthesiologists during the COVID-19 Outbreak in China.” Br J Anaesth 124, 6 (June 2020): 666–669
- An algorithm for the interaction of specialists from the Center for Anesthesiology and Intensive Care with doctors of hospitals has been developed and is successfully applied in practice. INTENSIVE CARE SERVICE OPTIMIZATION FOR COVID-19 PANDEMIC IN ALMATY CITY
- Blumenthal et al. “Covid-19 – Implications for the Health Care System.” N Engl J Med 383, 15 (2020): 1483-1488
- Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. “Vital surveillances: the epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) – China.” China CDC Weekly 2, 8 (2020): 113-122
- Alqahtani, Jaber S., TemitopeOyelade, Ali M. Aldhahir, Saleh M. Alghamdi, MeshalAlmehmadi, Abdulaziz S. Alqahtani, et al. “Prevalence, Severity and Mortality Associated with COPD and Smoking in Patients with COVID-19: A Rapid Systematic Review and Meta-Analysis.” PLoSOne 15, 5 (2020): e0233147
- Tabakokureniei COVID-19. Zayavlenie VOZ ot 11 maya 2020 g. ZHeneva: Vsemirnayaorganizaciyazdravoohraneniya; 2020 (https://www.who.int/ru/ news-room/detail/11-05-2020-who-statement-tobacco-use-and-covid-19, posostoyaniyuna 29 maya 2020 g.)
- Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. N Engl J Med. 2020;382:2012-22
- Grasselli, G., Zangrillo, A., Zanella, A., et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA (2020). doi:10.1001/jama.2020.5394
- Yang, X., Yu, Y., Xu, J., et al. “Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.” Lancet Respiratory Medicine 8 (2020): 475-81
- Mitra, A.R., N.A. Fergusson, E. Lloyd-Smith, et al. “Baseline characteristics and outcomes of patients with COVID-19 admitted to intensive care units in Vancouver, Canada: a case series.” Canadian Medical Association Journal 192, 26 (2020): E694-E701
- Phua, J., Weng, L., Ling, L., Egi, M., Lim, C.M., Divatia, J.V., et al. “Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations.” Lancet Respiratory Medicine 8, 5 (2020): 506-517
- Guan, Wei-jie, Zheng-yi Ni, Yu Hu, Wen-hua Liang, Chun-quanOu, Jian-xing He, et al. “Clinical Characteristics of Coronavirus Disease 2019 in China.” New England Journal of Medicine 382, 18 (2020): 1708-1720
- Opytgosudarstv v bor’be s pandemiej COVID-19. Sbornik stranovyh kejsov. Schetnayapalata Rossijskoj Federacii. 2020
- National Health Service, Improvement. “Specialty Guides for Patient Management During the Coronavirus Pandemic: Clinical Guide for Renal Replacement Therapy Options in Critical Care During the Coronavirus Pandemic.” England.nhs.uk,
- Singh, Anoop K., Rajeev Gupta, and Anoop Misra. “Comorbidities in COVID-19: Outcomes in Hypertensive Cohort and Controversies with Renin Angiotensin System Blockers.” Diabetes Metabolism Syndrome 14, 4 (2020): 283-287
- Wu, Chaomin, Xiaoyan Chen, YanpingCai, Jiehua Xia, Xing Zhou, Sheng Xu, et al. “Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China.” JAMA InternalMedicine 180, 7 (2020): 934
- The average number of resuscitation patients who were daily in the city hospitals in July was 37.1 patients, of which 24.3% were patients in an extremely serious unstable condition. The main comorbidities were pathologies of the heart, brain, and kidneys. The severe course of pneumonia with coronavirus infection is accompanied by a high mortality rate. The work of the resuscitation service in Almaty was optimized by creating an Anesthesiology and Resuscitation Center for the treatment of critically ill patients with COVID-19. The functioning of the Center leads to an improvement in treatment results, in the form of a significant reduction in mortality, which is confirmed by the odds ratio (OR) = 3.39 and relative risk (RR) = 1.57
- Bindom, Susan M., and Eric Lazartigues. “The Sweeter Side of ACE2: Physiological Evidence for a Role in Diabetes.” MolecularandCellularEndocrinology 302, 2 (2009): 193-202
- Burke, R. M., Midgley, C. M., Dratch, A., Fenstersheib, M., Haupt, T., Holshue, M., et al. “Active monitoring of persons exposed to patients with confirmed COVID-19 — United States, January–February 2020.” MMWR MorbidityandMor talityWeeklyRepor t (2020)
- Huang, R., Xia, J., Chen, Y., Shan, C., Wu, C. “A family cluster of SARS-CoV-2 infection involving 11 patients in Nanjing, China.” Lancet Infectious Diseases 20, no. 5 INTENSIVE CARE SERVICE OPTIMIZATION FOR
- Pan, X., Chen, D., Xia, Y., Wu, X., Li, T., Ou, X., et al. “Asymptomatic cases in a family cluster with SARS-CoV-2 infection.” LancetInfectiousDiseases 20, 4 (2020): 410-411
- Tong, Z. D., Tang, A., Li, K. F., Li, P., Wang, H. L., Yi, J. P., et al. “Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020.” Emerging Infectious Diseases 26, 5 (2020): 1052-1054
- Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.” Lancet. 2020;395(10223):497-506
- Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., ...& Guan, L. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 2020. 395(10229), 1054-1062